PM Modi visits Bharat Biotech's vaccine manufacturing facility in Hyderabad

Covaxin, being developed by Bharat Biotech in collaboration with the
Indian Council of Medical Research and National Institute of Virology,
is now undergoing phase-3 trials. The Phase-3 trials involve 26,000
volunteers across India, conducted in partnership with ICMR.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pm-modi-visits-bharat-biotechs-vaccine-manufacturing-facility-in-hyderabad/articleshow/79462953.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply